You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

~ Buy the STENDRA (avanafil) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR STENDRA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for STENDRA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00790751 ↗ Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED Completed VIVUS, Inc. Phase 3 2008-11-01 This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.
NCT00809471 ↗ Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) Completed VIVUS, Inc. Phase 3 2008-12-01 This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.
NCT00853606 ↗ Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction Completed VIVUS, Inc. Phase 3 2009-03-01 This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
NCT00895011 ↗ Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy Completed VIVUS, Inc. Phase 3 2009-04-01 The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
NCT01768676 ↗ Study Evaluating the Effects of Avanafil on Semen Parameters Completed VIVUS, Inc. Phase 4 2012-12-01 The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
NCT02033200 ↗ Safety Study Looking at the Effects of Stendra on Vision Completed VIVUS, Inc. Phase 4 2014-01-01 The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for STENDRA

Condition Name

Condition Name for STENDRA
Intervention Trials
Erectile Dysfunction 5
Vision 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for STENDRA
Intervention Trials
Erectile Dysfunction 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for STENDRA

Trials by Country

Trials by Country for STENDRA
Location Trials
United States 81
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for STENDRA
Location Trials
Louisiana 5
Florida 5
California 5
Arizona 5
Texas 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for STENDRA

Clinical Trial Phase

Clinical Trial Phase for STENDRA
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for STENDRA
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for STENDRA

Sponsor Name

Sponsor Name for STENDRA
Sponsor Trials
VIVUS, Inc. 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for STENDRA
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.